Gene · 6571
Papers3,040
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,040
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ATF3 as a potential diagnostic marker of early-stage osteoarthritis and its correlation with immune infiltration through bioinformatics analysis. | Bone Joint Res | 2022 | 36082523 | PubTator, text mining | PubMed |
| The regulatory role of AP-2β in monoaminergic neurotransmitter systems: insights on its signalling pathway, linked disorders and theragnostic potential. | Cell Biosci | 2022 | 36076256 | PubTator, text mining | PubMed |
| [18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism. | EJNMMI Res | 2022 | 36070114 | PubTator, text mining | PubMed |
| Fezf2-positive fork cell-like neurons in the mouse insular cortex. | PLoS One | 2022 | 36067159 | PubTator, text mining | PubMed |
| Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression? | Front Pharmacol | 2022 | 36059987 | PubTator, text mining | PubMed |
| The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders. | Mov Disord | 2022 | 36054588 | PubTator, text mining | PubMed |
| Compendium of proteins containing segments that exhibit zero-tolerance to amino acid variation in humans. | Protein Sci | 2022 | 36040257 | PubTator, text mining | PubMed |
| The therapeutic potential of exercise and caffeine on attention-deficit/hyperactivity disorder in athletes. | Front Neurosci | 2022 | 36033633 | PubTator, text mining | PubMed |
| An Association Study of DNA Methylation and Gene Expression in Angelman Syndrome: A Bioinformatics Approach. | Int J Mol Sci | 2022 | 36012404 | PubTator, text mining | PubMed |
| Therapeutic Strategies in Huntington's Disease: From Genetic Defect to Gene Therapy. | Biomedicines | 2022 | 36009443 | PubTator, text mining | PubMed |
| Addressing the Neuroprotective Actions of Coffee in Parkinson's Disease: An Emerging Nutrigenomic Analysis. | Antioxidants (Basel) | 2022 | 36009304 | PubTator, text mining | PubMed |
| Beneficial Influence of Exendin-4 on Specific Organs and Mechanisms Favourable for the Elderly with Concomitant Obstructive Lung Diseases. | Brain Sci | 2022 | 36009152 | PubTator, text mining | PubMed |
| Molecular and cellular evolution of the primate dorsolateral prefrontal cortex. | Science | 2022 | 36007006 | PubTator, text mining | PubMed |
| Dopaminergic Neurons Differentiated from LRRK2 I1371V-Induced Pluripotent Stem Cells Display a Lower Yield, α-Synuclein Pathology, and Functional Impairment. | ACS Chem Neurosci | 2022 | 36006382 | PubTator, text mining | PubMed |
| Striatal dopamine dissociates methylphenidate effects on value-based versus surprise-based reversal learning. | Nat Commun | 2022 | 36002446 | PubTator, text mining | PubMed |
| Role of Protein Damage Inflicted by Dopamine Metabolites in Parkinson's Disease: Evidence, Tools, and Outlook. | Chem Res Toxicol | 2022 | 35994383 | PubTator, text mining | PubMed |
| Humanized substitutions of Vmat1 in mice alter amygdala-dependent behaviors associated with the evolution of anxiety. | iScience | 2022 | 35992083 | PubTator, text mining | PubMed |
Case report: Combined therapy of bilateral subthalamic nucleus deep brain stimulation and spinal cord stimulation significantly improves motor function in a patient with multiple system atrophy with predominant parkinsonism. | Front Neurosci | 2022 | 35979336 | PubTator, text mining | PubMed |
| Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma. | Front Endocrinol (Lausanne) | 2022 | 35957826 | PubTator, text mining | PubMed |
| Nitrosative stress in Parkinson's disease. | NPJ Parkinsons Dis | 2022 | 35953517 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6571/papers?page=28